The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1530985/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832557414259359744 |
|---|---|
| author | Jonathan D. Douros Jonathan N. Flak Jonathan N. Flak Patrick J. Knerr |
| author_facet | Jonathan D. Douros Jonathan N. Flak Jonathan N. Flak Patrick J. Knerr |
| author_sort | Jonathan D. Douros |
| collection | DOAJ |
| format | Article |
| id | doaj-art-f190853599a54475b970f2fda7d06e4e |
| institution | Kabale University |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-f190853599a54475b970f2fda7d06e4e2025-02-03T05:11:59ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-02-011610.3389/fendo.2025.15309851530985The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIPJonathan D. Douros0Jonathan N. Flak1Jonathan N. Flak2Patrick J. Knerr3Indiana Biosciences Research Institute, Indianapolis, IN, United StatesIndiana Biosciences Research Institute, Indianapolis, IN, United StatesDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United StatesIndiana Biosciences Research Institute, Indianapolis, IN, United Stateshttps://www.frontiersin.org/articles/10.3389/fendo.2025.1530985/fullGLP-1 - glucagon-like peptide-1GIP - glucose-dependent insulinotropic peptideobesityincretinpharmacology |
| spellingShingle | Jonathan D. Douros Jonathan N. Flak Jonathan N. Flak Patrick J. Knerr The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP Frontiers in Endocrinology GLP-1 - glucagon-like peptide-1 GIP - glucose-dependent insulinotropic peptide obesity incretin pharmacology |
| title | The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP |
| title_full | The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP |
| title_fullStr | The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP |
| title_full_unstemmed | The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP |
| title_short | The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP |
| title_sort | agony and the efficacy central mechanisms of glp 1 induced adverse events and their mitigation by gip |
| topic | GLP-1 - glucagon-like peptide-1 GIP - glucose-dependent insulinotropic peptide obesity incretin pharmacology |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2025.1530985/full |
| work_keys_str_mv | AT jonathanddouros theagonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip AT jonathannflak theagonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip AT jonathannflak theagonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip AT patrickjknerr theagonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip AT jonathanddouros agonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip AT jonathannflak agonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip AT jonathannflak agonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip AT patrickjknerr agonyandtheefficacycentralmechanismsofglp1inducedadverseeventsandtheirmitigationbygip |